authors
- Gerstein, Hertzel Chaim
- Wolsk, Emil
- Claggett, Brian
- Diaz, Rafael
- Dickstein, Kenneth
- Hess, Sibylle
- Køber, Lars
- Maggioni, Aldo P
- McMurray, John JV
- Probstfield, Jeffrey L
- Riddle, Matthew C
- Tardif, Jean‐Claude
- Pfeffer, Marc A
Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- April 2023
has subject area
- 1103 Clinical Sciences (FoR)
- Acute Coronary Syndrome (MeSH)
- Diabetes Mellitus, Type 2 (MeSH)
- Endocrinology & Metabolism (Science Metrix)
- Glucagon-Like Peptide-1 Receptor (MeSH)
- Humans (MeSH)
- Hypoglycemic Agents (MeSH)
- Natriuretic Peptides (MeSH)
- Peptides (MeSH)
published in
- Diabetes, Obesity and Metabolism Journal